Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

MeVis Medical Solutions AG, DE000A0LBFE4

MeVis Medical Solutions AG, DE000A0LBFE4

25.06.2020 - 15:42:14

MeVis Medical Solutions AG: Correction of a release from 24/06/2020 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Notification of Major Holdings

1. Details of issuer Name: MeVis Medical Solutions AG Street: Caroline-Herschel-Str. 1 Postal code: 28359 City: BremenGermany Legal Entity Identifier (LEI): 529900Z8B6L1WCLNHW14 2. Reason for notification X Acquisition/disposal of shares with voting rights   Acquisition/disposal of instruments   Change of breakdown of voting rights X Other reason:Withdrawal of a notification of voting rights (see item 10) 3. Details of person subject to the notification obligation Legal entity: HANSAINVEST Hanseatische Investment-GmbHCity of registered office, country: Hamburg, Germany 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3.  5. Date on which threshold was crossed or reached: 22 Jun 2020 6. Total positions   % of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) Total of both in % (7.a. + 7.b.) Total number of voting rights pursuant to Sec. 41 WpHG New % % % Previous notification % % % / 7. Details on total positions a. Voting rights attached to shares (Sec. 33, 34 WpHG) ISIN Absolute In %   Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) Direct (Sec. 33 WpHG) Indirect (Sec. 34 WpHG) % % Total % b.1. Instruments according to Sec. 38 (1) no. 1 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in % %     Total % b.2. Instruments according to Sec. 38 (1) no. 2 WpHG Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in % %       Total % 8. Information in relation to the person subject to the notification obligationX Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).   Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)   9. In case of proxy voting according to Sec. 34 para. 3 WpHG (only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG) Date of general meeting: Holding total positions after general meeting (6.) after annual general meeting:Proportion of voting rights Proportion of instruments Total of both % % % 10. Other explanatory remarks:The voting rights announcement of June 23, 2020 (published on June 24, 2020) is hereby withdrawn, as the threshold of 10% was not exceeded. Thus, the proportion of voting rights of HANSAINVEST Hanseatische Investment-GmbH in Mevis Medical Solutions AG continues to be above 5% and below 10%.  Date25 Jun 2020

25.06.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: MeVis Medical Solutions AG Caroline-Herschel-Str. 1 28359 Bremen

Germany Internet: http://www.mevis.de   End of News DGAP News Service

1079281  25.06.2020 

@ dgap.de